IL17A and psoriasis: The 2020 research [77] indicates that there is enhanced acetylation of H3K9 and H3K27 in the IL17A promoter region in the immune cells of psoriasis patients, which induced differentiation of Th17 and γδ T17 cells (which produce IL-17A γδ T cells), resulting in immune imbalance and disease progression.